| 2026-08-17 | Press release | Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans |
| 2026-08-17 | 8-K | Form 8-K, Item 7.01 |
| 2026-08-10 | Transcript | Q2 FY26 earnings call transcript |
| 2026-08-10 | Press release | Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search · Q2 2026 |
| 2026-08-10 | Press release | Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value |
| 2026-08-10 | Press release | Accendra Health Reports Second Quarter 2026 Financial Results |
| 2026-08-10 | Supplement | Second Quarter 2026 Continuing Operations Supplemental Slides |
| 2026-08-10 | Press release | Accendra Health Reports Second Quarter 2026 Financial Results |
| 2026-08-10 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-10 | 8-K | Form 8-K, Item 1.01 |
| 2026-08-10 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-27 | Press release | Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call |
| 2026-07-27 | Press release | Accendra Health Announces Leadership Appointments in IT and Procurement |
| 2026-06-25 | 8-K | Form 8-K, Item 8.01 |
| 2026-06-23 | Press release | Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations |
| 2026-06-15 | 8-K | Form 8-K, Item 1.01 |
| 2026-06-10 | Press release | Accendra Health Announces Early Results of Offers and Consent Solicitations |
| 2026-05-22 | Press release | Accendra Health Announces Offers and Consent Solicitations |
| 2026-05-22 | 8-K | Form 8-K, Item 7.01 |
| 2026-05-15 | 8-K | Form 8-K, Item 5.02 |
| 2026-05-11 | Press release | Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction Commitments in Place from Existing Creditors to Strengthen Balance Sheet, Extend Maturities, and Reduce Leverage |
| 2026-05-11 | Press release | Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Tran |
| 2026-05-11 | Press release | Press Release of Q1 2026 |
| 2026-05-11 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-11 | 8-K | Form 8-K, Item 1.01 |
| 2026-05-11 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-05-01 | Press release | Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call |
| 2026-04-02 | Proxy | 2026 Proxy Statement of 2025 Annual Report |
| 2026-04-02 | Proxy | Definitive proxy statement |
| Transcript | Q1 FY26 earnings call transcript |
| 2026-03-24 | Annual report | 2025 Annual Report of 2025 Annual Report |
| 2026-02-20 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-19 | Press release | Download , Accendra Health Reports Fourth Quarter 2025 Financial Results |
| 2026-02-19 | Press release | Press release · Q4 2025 · Feb 2026 |
| 2026-02-19 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-05 | Press release | Download , Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call, (o |
| 2026-01-05 | 8-K | Form 8-K/A, Item 9.01 |
| 2026-01-02 | Press release | Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH” |
| 2025-12-31 | 8-K | Form 8-K, Item 1.01 |
| Transcript | Q4 FY25 earnings call transcript |